Volume 17, Number 11—November 2011
CME ACTIVITY - Research
Global Distribution and Epidemiologic Associations of Escherichia coli Clonal Group A, 1998–2007
Table 2
Phylogenetic group and clonal group A status | No. clonal group A isolates/total no. isolates (%) | p value† | ||
---|---|---|---|---|
Total, n = 2,210 | TMP/SMZ susceptible, n = 1,083 | TMP/SMZ resistant, n = 1,127 | ||
E. coli phylogenetic group | ||||
A | 345 (15.6) | 141 (13.0) | 204 (18.1) | 0.001 |
B1 | 223 (10.1) | 121 (11.2) | 102 (9.1) | |
B2 | 1,071 (48.5) | 633 (58.4) | 438 (38.9) | <0.001 |
D | 571 (25.8) | 188 (17.4) | 383 (34.0) | <0.001 |
Clonal group A | 144 (6.5) | 30 (2.8) | 114 (10.1) | <0.001 |
*TMP/SMZ, trimethoprim/sulfamethoxazole.
*TMP/SMZ, trimethoprim/sulfamethoxazole. |
*TMP/SMZ, trimethoprim/sulfamethoxazole.
†p values, by Fisher exact test, for TMP/SMZ-susceptible vs. -resistant isolates are shown where p<0.05; otherwise, p>0.10.
1Investigators who contributed data are listed at the end of this article.
Page created: October 21, 2011
Page updated: October 21, 2011
Page reviewed: October 21, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.